Resultats a la cerca d'autor :: APM

1

$A phase II study of Campath‐1H in children with relapsed or refractory acute lymphoblastic leukemia: A Children's Oncology Group report$

A phase II study of Campath‐1H in children with relapsed or refractory acute lymphoblastic leukemia: A Children's Oncology Group report per Anne Angiolillo, Alice L. Yu, Gregory H. Reaman, Ashish M. Ingle, Rita Secola, Peter C. Adamson

Publicat 2009

Obtenir text complet
Artigo

Afegir a favorits

Guardat en:
2

$Safety, Pharmacokinetics, and Immunomodulatory Effects of Lenalidomide in Children and Adolescents With Relapsed/Refractory Solid Tumors or Myelodysplastic Syndrome: A Children's Oncology Group Phase I Consortium Report$

Safety, Pharmacokinetics, and Immunomodulatory Effects of Lenalidomide in Children and Adolescents With Relapsed/Refractory Solid Tumors or Myelodysplastic Syndrome: A Children's O... per Stacey L. Berg, Mitchell S. Cairo, Heidi V. Russell, Janet Ayello, Ashish M. Ingle, Henry Lau, Nianhang Chen, Peter C. Adamson, Susan M. Blaney

Publicat 2010

Obtenir text complet Obtenir text complet
Artigo

Afegir a favorits

Guardat en:
3

Pediatric Phase I Trial and Pharmacokinetic Study of Dasatinib: A Report From the Children's Oncology Group Phase I Consortium per Richard Aplenc, Susan M. Blaney, Lewis C. Strauss, Frank M. Balis, Suzanne Shusterman, Ashish M. Ingle, Shruti Agrawal, Junfeng Sun, James R. Wright, Peter C. Adamson

Publicat 2011

Obtenir text complet
Artigo

Afegir a favorits

Guardat en:
4

$Phase 1 Study of Valproic Acid in Pediatric Patients with Refractory Solid or CNS Tumors: A Children's Oncology Group Report$

Phase 1 Study of Valproic Acid in Pediatric Patients with Refractory Solid or CNS Tumors: A Children's Oncology Group Report per Jack M. Su, Xiao‐Nan Li, Patrick Thompson, Ching-Nan Ou, Ashish M. Ingle, Heidi V. Russell, Ching C. Lau, Peter C. Adamson, Susan M. Blaney

Publicat 2010

Obtenir text complet Obtenir text complet
Artigo

Afegir a favorits

Guardat en:
5

$Phase 1 trial of temsirolimus in combination with irinotecan and temozolomide in children, adolescents and young adults with relapsed or refractory solid tumors: A children's oncology group study$

Phase 1 trial of temsirolimus in combination with irinotecan and temozolomide in children, adolescents and young adults with relapsed or refractory solid tumors: A children's oncol... per Rochelle Bagatell, Robin E. Norris, Ashish M. Ingle, Charlotte H. Ahern, Stephan D. Voss, Elizabeth Fox, Anthony Little, Brenda J. Weigel, Peter C. Adamson, Susan M. Blaney

Publicat 2013

Obtenir text complet
Artigo

Afegir a favorits

Guardat en:
6

$Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: A Children's Oncology Group phase I consortium study$

Phase I trial of two schedules of vincristine, oral irinotecan, and temozolomide (VOIT) for children with relapsed or refractory solid tumors: A Children's Oncology Group phase I c... per Lars M. Wagner, John P. Perentesis, Joel M. Reid, Matthew M. Ames, Stephanie L. Safgren, Marvin D. Nelson, Ashish M. Ingle, Susan M. Blaney, Peter C. Adamson

Publicat 2010

Obtenir text complet Obtenir text complet
Artigo

Afegir a favorits

Guardat en:
7

Pediatric Phase I and Pharmacokinetic Study of Erlotinib Followed by the Combination of Erlotinib and Temozolomide: A Children's Oncology Group Phase I Consortium Study per Regina I. Jakacki, Marta Hamilton, Richard J. Gilbertson, Susan M. Blaney, Jean M. Tersak, Mark Krailo, Ashish M. Ingle, Stephan D. Voss, Janet Dancey, Peter C. Adamson

Publicat 2008

Obtenir text complet Obtenir text complet
Artigo

Afegir a favorits

Guardat en:
8

$A Phase I Trial of Imetelstat in Children with Refractory or Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Study (ADVL1112)$

A Phase I Trial of Imetelstat in Children with Refractory or Recurrent Solid Tumors: A Children's Oncology Group Phase I Consortium Study (ADVL1112) per Patrick A. Thompson, Rachid Drissi, Jodi A. Muscal, Eshini Panditharatna, Maryam Fouladi, Ashish M. Ingle, Charlotte H. Ahern, Joel M. Reid, Tong Lin, Brenda J. Weigel, Susan M. Blaney

Publicat 2013

Obtenir text complet Obtenir text complet
Artigo

Afegir a favorits

Guardat en:
9

$A Phase I Trial and Pharmacokinetic Study of Sorafenib in Children with Refractory Solid Tumors or Leukemias: A Children's Oncology Group Phase I Consortium Report$

A Phase I Trial and Pharmacokinetic Study of Sorafenib in Children with Refractory Solid Tumors or Leukemias: A Children's Oncology Group Phase I Consortium Report per Brigitte C. Widemann, AeRang Kim, Elizabeth Fox, Sylvain Baruchel, Peter C. Adamson, Ashish M. Ingle, Julia Glade Bender, Michael Burke, Brenda J. Weigel, Diana Stempak, Frank M. Balis, Susan M. Blaney

Publicat 2012

Obtenir text complet
Artigo

Afegir a favorits

Guardat en:
10

$Phase I and Pharmacokinetic Study of Sunitinib in Pediatric Patients with Refractory Solid Tumors: A Children's Oncology Group Study$

Phase I and Pharmacokinetic Study of Sunitinib in Pediatric Patients with Refractory Solid Tumors: A Children's Oncology Group Study per Steven G. DuBois, Suzanne Shusterman, Ashish M. Ingle, Charlotte H. Ahern, Joel M. Reid, Bing Wu, Sylvain Baruchel, Julia Glade Bender, Percy Ivy, Holcombe E. Grier, Peter C. Adamson, Susan M. Blaney

Publicat 2011

Obtenir text complet Obtenir text complet
Artigo

Afegir a favorits

Guardat en:
11

$Phase I Pharmacokinetic and Pharmacodynamic Study of Pazopanib in Children With Soft Tissue Sarcoma and Other Refractory Solid Tumors: A Children's Oncology Group Phase I Consortium Report$

Phase I Pharmacokinetic and Pharmacodynamic Study of Pazopanib in Children With Soft Tissue Sarcoma and Other Refractory Solid Tumors: A Children's Oncology Group Phase I Consortiu... per Julia Glade Bender, Alice Lee, Joel M. Reid, Sylvain Baruchel, Timothy P. L. Roberts, Stephan D. Voss, Bing Wu, Charlotte H. Ahern, Ashish M. Ingle, Pamela Jo Harris, Brenda J. Weigel, Susan M. Blaney

Publicat 2013

Obtenir text complet Obtenir text complet
Artigo

Afegir a favorits

Guardat en:
12

$A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: A Children's Oncology Group phase I consortium study (ADVL0916)$

A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: A Children's Oncology Group phase I consortium study (ADVL0916) per Jodi A. Muscal, Patrick A. Thompson, Terzah M. Horton, Ashish M. Ingle, Charlotte H. Ahern, Renee M. McGovern, Joel M. Reid, Matthew M. Ames, Igor Espinoza‐Delgado, Brenda J. Weigel, Susan M. Blaney

Publicat 2012

Obtenir text complet
Artigo

Afegir a favorits

Guardat en:
13

Pediatric Phase I Trial and Pharmacokinetic Study of Vorinostat: A Children's Oncology Group Phase I Consortium Report per Maryam Fouladi, Julie R. Park, Clinton F. Stewart, Richard J. Gilbertson, Paula Schaiquevich, Junfeng Sun, Joel M. Reid, Matthew M. Ames, Roseanne Speights, Ashish M. Ingle, James A. Zwiebel, Susan M. Blaney, Peter C. Adamson

Publicat 2010

Obtenir text complet Obtenir text complet
Artigo

Afegir a favorits

Guardat en:
14

$Phase I Study of Depsipeptide in Pediatric Patients With Refractory Solid Tumors: A Children's Oncology Group Report$

Phase I Study of Depsipeptide in Pediatric Patients With Refractory Solid Tumors: A Children's Oncology Group Report per Maryam Fouladi, Wayne L. Furman, Thomas K. Chin, Burgess B. Freeman, Lorina Dudkin, Clinton F. Stewart, Mark Krailo, Roseanne Speights, Ashish M. Ingle, Peter J. Houghton, James R. Wright, Peter C. Adamson, Susan M. Blaney

Publicat 2006

Obtenir text complet Obtenir text complet
Artigo

Afegir a favorits

Guardat en:
15

$A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: A children's oncology group phase 1 consortium study$

A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: A children's oncology group phase 1 consortium study per Trent R. Hummel, Lars M. Wagner, Charlotte H. Ahern, Maryam Fouladi, Joel M. Reid, Renee M. McGovern, Matthew M. Ames, Richard J. Gilbertson, Terzah M. Horton, Ashish M. Ingle, Brenda J. Weigel, Susan M. Blaney

Publicat 2013

Obtenir text complet
Artigo

Afegir a favorits

Guardat en:
16

$A Phase I Study of 17-Allylaminogeldanamycin in Relapsed/Refractory Pediatric Patients with Solid Tumors: A Children's Oncology Group Study$

A Phase I Study of 17-Allylaminogeldanamycin in Relapsed/Refractory Pediatric Patients with Solid Tumors: A Children's Oncology Group Study per Brenda J. Weigel, Susan M. Blaney, Joel M. Reid, Stephanie L. Safgren, Rochelle Bagatell, John Kersey, Joseph P. Neglia, S. Percy Ivy, Ashish M. Ingle, Luke Whitesell, Richard J. Gilbertson, Mark Krailo, Matthew M. Ames, Peter C. Adamson

Publicat 2007

Obtenir text complet Obtenir text complet
Artigo

Afegir a favorits

Guardat en:
17

$Phase I/II Trial and Pharmacokinetic Study of Cixutumumab in Pediatric Patients With Refractory Solid Tumors and Ewing Sarcoma: A Report From the Children's Oncology Group$

Phase I/II Trial and Pharmacokinetic Study of Cixutumumab in Pediatric Patients With Refractory Solid Tumors and Ewing Sarcoma: A Report From the Children's Oncology Group per Suman Malempati, Brenda J. Weigel, Ashish M. Ingle, Charlotte H. Ahern, Julie M. Carroll, Charles T. Roberts, Joel M. Reid, Stephen C. Schmechel, Stephan D. Voss, Steven Y. Cho, Helen X. Chen, Mark Krailo, Peter C. Adamson, Susan M. Blaney

Publicat 2011

Obtenir text complet
Artigo

Afegir a favorits

Guardat en:
18

$Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study$

Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study per Yaël P. Mossé, Megan S. Lim, Stephan D. Voss, Keith D. Wilner, Katherine Ruffner, Julie Laliberté, Delphine C.M. Rolland, Frank M. Balis, John M. Maris, Brenda J. Weigel, Ashish M. Ingle, Charlotte H. Ahern, Peter C. Adamson, Susan M. Blaney

Publicat 2013

Obtenir text complet
Artigo

Afegir a favorits

Guardat en:
19

$Phase I Trial and Pharmacokinetic Study of Bevacizumab in Pediatric Patients With Refractory Solid Tumors: A Children's Oncology Group Study$

Phase I Trial and Pharmacokinetic Study of Bevacizumab in Pediatric Patients With Refractory Solid Tumors: A Children's Oncology Group Study per Julia Glade Bender, Peter C. Adamson, Joel M. Reid, Lu Xu, Sylvain Baruchel, Yuval Shaked, Robert S. Kerbel, Erin Cooney-Qualter, Diana Stempak, Helen X. Chen, Marvin D. Nelson, Mark Krailo, Ashish M. Ingle, Susan M. Blaney, Jessica J. Kandel, Darrell J. Yamashiro

Publicat 2008

Obtenir text complet
Artigo

Afegir a favorits

Guardat en: